SEC Form D · filed March 8, 2017
RedShift BioAnalytics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (15)
Frank Smith · Burlington, MADirectorBryson Holliman · Burlington, MADirectorWilliam Cadogan · Burlington, MADirectorEugene Ma · Burlington, MAExecCharles Marshall · Burlington, MAExec · DirectorCatherine A. Cawthon · Dublin, OHDirectorStephen W. Farr · San Ramon, CADirectorKathleen A. Pecard · Brookfield, WIDirectorChristopher C. Cox · Lansing, MIExecCarl C. Riedy · Washington, Washington, D.C.Exec · DirectorKeith W. Bank · San Ramon, CADirectorFelix D. Navarro-Grau Hurtado · Vancouver, British Columbia, CanadaExecJoshua Pierce · San Francisco, CADirectorKimberly A. Arntson · Vancouver, British Columbia, CanadaExec · DirectorDaniel B. Stein · Fayetteville, ARDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗